Status:
COMPLETED
Evaluating the Immune Response for COVID-19
Lead Sponsor:
Assaf-Harofeh Medical Center
Conditions:
COVID-19
Eligibility:
All Genders
18+ years
Brief Summary
The 2019-20 coronavirus disease, caused by COVID-19, is an ongoing pandemic. The measures in which public health officials quarantine confirmed and isolate symptomatic cases in order to reduce the spr...
Detailed Description
The 2019-20 coronavirus disease, caused by COVID-19, is an ongoing pandemic. The outbreak started in Wuhan, Hubei province, China, in December 2019 and the World Health Organization (WHO) recognized i...
Eligibility Criteria
Inclusion
- Positive COVID-19 RT-PCR to the subject or his/her household.
- Over 18 years old
- Ability to sign an informed consent
Exclusion
- Inability to sign an informed consent
- Pregnancy
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 2 2022
Estimated Enrollment :
214 Patients enrolled
Trial Details
Trial ID
NCT04348422
Start Date
May 1 2020
End Date
February 2 2022
Last Update
June 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assaf-Harofeh Medical Center
Ramla, Israel, 70300